Suturion advances to final stage of global MedTech Innovator Accelerator

Suturion has been selected for the final round of the prestigious MedTech Innovator 2026 Accelerator Program. Out of more than 1,800 applicants worldwide, Suturion is among the top 10% invited to deliver a live pitch as part of the final selection process. The final cohort of 65 companies will be announced in May2026.

As part ofthe selection process, Suturion will present at the MedTech Innovator RadarForum, held April 7–9 in Manhattan Beach, California. The event brings together leading investors, strategic partners, and healthcare decision-makers, offering aunique platform for emerging companies shaping the future of healthcare.

In a strong validation of its innovation and clinical relevance, Suturion was specifically requested to pitch by a strategic corporate partner, highlighting the growing industry interest in its technology.

"This is anexciting and important recognition, not only for Suturion but also for SwedishMedTech innovation,” said Paan Hermansson, CEO of Suturion. “Being selected among the top MedTech innovators globally reinforces our mission to improve patient outcomes by enabling standardized, efficient, and safe abdominal wall closure. We look forward to engaging with global partners and accelerating our journey toward commercialization." - Paan Hermansson, CEO of Suturion.

MedTech Innovator is the world’s largest accelerator dedicated to medical technology, providing access to leading industry partners, investors, and expertise to help bring breakthrough innovations to patients worldwide.